With her doctors permission, she started microdosing a GLP-1 through Noom and has lost 13 pounds along with diet changes and intentional eating
Robert Kushner, professor of medicine at Northwestern University Feinberg School of Medicine and an investigator in multiple obesity pharmacotherapy trials, has stated: "Triple-receptor agonists represent the next frontier
The exact mechanisms through which activation of THR improves MASH are still unclear but are known to control fat synthesis, regulate fatty acid oxidation, regulate cholesterol metabolism, improve mitochondrial function, and reduce inflammation and fibrosis
I experienced: Significant nausea Appetite suppression that felt extreme Hair shedding during rapid weight loss A 15-pound weight reduction While the weight loss occurred, the side effects were difficult for me
For more on oral options, see our guide on oral semaglutide drops
But the brain doesnt compartmentalize the way pharmaceutical labels do and thats where the story gets fascinating
